Global Gastrointestinal OTC Drugs Market Research Report 2026(Status and Outlook)
Gastrointestinal OTC drugs are used for indications such as GERD, vomiting, constipation, diarrhea, and flatulence. Some of the OTC drugs that are available for the treatment of gastrointestinal diseases are laxatives, anti-flatulents, H2-antaginists, anti-diarrheals, PPIs, and anti-emetics. The OTC drugs are not bound by regulatory guidelines, but need to comply with the drug monograph of a country.
The global Gastrointestinal OTC Drugs market size was estimated at USD 6488.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Gastrointestinal OTC Drugs market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Gastrointestinal OTC Drugs market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Gastrointestinal OTC Drugs market.
Global Gastrointestinal OTC Drugs Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
GlaxoSmithKline
Pfizer
Johnson & Johnson
Bayer
Procter & Gamble
Perrigo
Abbott
Sanofi
Teva Pharmaceutical
Nestle
Boehringer Ingelheim
Reckitt Benckiser
Purdue Pharma
Market Segmentation (by Type)
Laxatives
Anti-Flatulents
H2-Antaginists
Anti-Diarrheals
PPIs
Anti-Emetics
Other
Market Segmentation (by Application)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Gastrointestinal OTC Drugs Market
Overview of the regional outlook of the Gastrointestinal OTC Drugs Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gastrointestinal OTC Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Gastrointestinal OTC Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Gastrointestinal OTC Drugs market size was estimated at USD 6488.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Gastrointestinal OTC Drugs market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Gastrointestinal OTC Drugs market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Gastrointestinal OTC Drugs market.
Global Gastrointestinal OTC Drugs Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
GlaxoSmithKline
Pfizer
Johnson & Johnson
Bayer
Procter & Gamble
Perrigo
Abbott
Sanofi
Teva Pharmaceutical
Nestle
Boehringer Ingelheim
Reckitt Benckiser
Purdue Pharma
Market Segmentation (by Type)
Laxatives
Anti-Flatulents
H2-Antaginists
Anti-Diarrheals
PPIs
Anti-Emetics
Other
Market Segmentation (by Application)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Gastrointestinal OTC Drugs Market
Overview of the regional outlook of the Gastrointestinal OTC Drugs Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gastrointestinal OTC Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Gastrointestinal OTC Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Gastrointestinal OTC Drugs
1.2 Key Market Segments
1.2.1 Gastrointestinal OTC Drugs Segment by Type
1.2.2 Gastrointestinal OTC Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GASTROINTESTINAL OTC DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gastrointestinal OTC Drugs Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Gastrointestinal OTC Drugs Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GASTROINTESTINAL OTC DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Gastrointestinal OTC Drugs Product Life Cycle
3.3 Global Gastrointestinal OTC Drugs Sales by Manufacturers (2020-2025)
3.4 Global Gastrointestinal OTC Drugs Revenue Market Share by Manufacturers (2020-2025)
3.5 Gastrointestinal OTC Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Gastrointestinal OTC Drugs Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Gastrointestinal OTC Drugs Market Competitive Situation and Trends
3.8.1 Gastrointestinal OTC Drugs Market Concentration Rate
3.8.2 Global 5 and 10 Largest Gastrointestinal OTC Drugs Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GASTROINTESTINAL OTC DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Gastrointestinal OTC Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GASTROINTESTINAL OTC DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Gastrointestinal OTC Drugs Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Gastrointestinal OTC Drugs Market
5.7 ESG Ratings of Leading Companies
6 GASTROINTESTINAL OTC DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gastrointestinal OTC Drugs Sales Market Share by Type (2020-2025)
6.3 Global Gastrointestinal OTC Drugs Market Size by Type (2020-2025)
6.4 Global Gastrointestinal OTC Drugs Price by Type (2020-2025)
7 GASTROINTESTINAL OTC DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gastrointestinal OTC Drugs Market Sales by Application (2020-2025)
7.3 Global Gastrointestinal OTC Drugs Market Size (M USD) by Application (2020-2025)
7.4 Global Gastrointestinal OTC Drugs Sales Growth Rate by Application (2020-2025)
8 GASTROINTESTINAL OTC DRUGS MARKET SALES BY REGION
8.1 Global Gastrointestinal OTC Drugs Sales by Region
8.1.1 Global Gastrointestinal OTC Drugs Sales by Region
8.1.2 Global Gastrointestinal OTC Drugs Sales Market Share by Region
8.2 Global Gastrointestinal OTC Drugs Market Size by Region
8.2.1 Global Gastrointestinal OTC Drugs Market Size by Region
8.2.2 Global Gastrointestinal OTC Drugs Market Size by Region
8.3 North America
8.3.1 North America Gastrointestinal OTC Drugs Sales by Country
8.3.2 North America Gastrointestinal OTC Drugs Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Gastrointestinal OTC Drugs Sales by Country
8.4.2 Europe Gastrointestinal OTC Drugs Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Gastrointestinal OTC Drugs Sales by Region
8.5.2 Asia Pacific Gastrointestinal OTC Drugs Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Gastrointestinal OTC Drugs Sales by Country
8.6.2 South America Gastrointestinal OTC Drugs Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Gastrointestinal OTC Drugs Sales by Region
8.7.2 Middle East and Africa Gastrointestinal OTC Drugs Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GASTROINTESTINAL OTC DRUGS MARKET PRODUCTION BY REGION
9.1 Global Production of Gastrointestinal OTC Drugs by Region(2020-2025)
9.2 Global Gastrointestinal OTC Drugs Revenue Market Share by Region (2020-2025)
9.3 Global Gastrointestinal OTC Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Gastrointestinal OTC Drugs Production
9.4.1 North America Gastrointestinal OTC Drugs Production Growth Rate (2020-2025)
9.4.2 North America Gastrointestinal OTC Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Gastrointestinal OTC Drugs Production
9.5.1 Europe Gastrointestinal OTC Drugs Production Growth Rate (2020-2025)
9.5.2 Europe Gastrointestinal OTC Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Gastrointestinal OTC Drugs Production (2020-2025)
9.6.1 Japan Gastrointestinal OTC Drugs Production Growth Rate (2020-2025)
9.6.2 Japan Gastrointestinal OTC Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Gastrointestinal OTC Drugs Production (2020-2025)
9.7.1 China Gastrointestinal OTC Drugs Production Growth Rate (2020-2025)
9.7.2 China Gastrointestinal OTC Drugs Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Basic Information
10.1.2 GlaxoSmithKline Gastrointestinal OTC Drugs Product Overview
10.1.3 GlaxoSmithKline Gastrointestinal OTC Drugs Product Market Performance
10.1.4 GlaxoSmithKline Business Overview
10.1.5 GlaxoSmithKline SWOT Analysis
10.1.6 GlaxoSmithKline Recent Developments
10.2 Pfizer
10.2.1 Pfizer Basic Information
10.2.2 Pfizer Gastrointestinal OTC Drugs Product Overview
10.2.3 Pfizer Gastrointestinal OTC Drugs Product Market Performance
10.2.4 Pfizer Business Overview
10.2.5 Pfizer SWOT Analysis
10.2.6 Pfizer Recent Developments
10.3 Johnson and Johnson
10.3.1 Johnson and Johnson Basic Information
10.3.2 Johnson and Johnson Gastrointestinal OTC Drugs Product Overview
10.3.3 Johnson and Johnson Gastrointestinal OTC Drugs Product Market Performance
10.3.4 Johnson and Johnson Business Overview
10.3.5 Johnson and Johnson SWOT Analysis
10.3.6 Johnson and Johnson Recent Developments
10.4 Bayer
10.4.1 Bayer Basic Information
10.4.2 Bayer Gastrointestinal OTC Drugs Product Overview
10.4.3 Bayer Gastrointestinal OTC Drugs Product Market Performance
10.4.4 Bayer Business Overview
10.4.5 Bayer Recent Developments
10.5 Procter and Gamble
10.5.1 Procter and Gamble Basic Information
10.5.2 Procter and Gamble Gastrointestinal OTC Drugs Product Overview
10.5.3 Procter and Gamble Gastrointestinal OTC Drugs Product Market Performance
10.5.4 Procter and Gamble Business Overview
10.5.5 Procter and Gamble Recent Developments
10.6 Perrigo
10.6.1 Perrigo Basic Information
10.6.2 Perrigo Gastrointestinal OTC Drugs Product Overview
10.6.3 Perrigo Gastrointestinal OTC Drugs Product Market Performance
10.6.4 Perrigo Business Overview
10.6.5 Perrigo Recent Developments
10.7 Abbott
10.7.1 Abbott Basic Information
10.7.2 Abbott Gastrointestinal OTC Drugs Product Overview
10.7.3 Abbott Gastrointestinal OTC Drugs Product Market Performance
10.7.4 Abbott Business Overview
10.7.5 Abbott Recent Developments
10.8 Sanofi
10.8.1 Sanofi Basic Information
10.8.2 Sanofi Gastrointestinal OTC Drugs Product Overview
10.8.3 Sanofi Gastrointestinal OTC Drugs Product Market Performance
10.8.4 Sanofi Business Overview
10.8.5 Sanofi Recent Developments
10.9 Teva Pharmaceutical
10.9.1 Teva Pharmaceutical Basic Information
10.9.2 Teva Pharmaceutical Gastrointestinal OTC Drugs Product Overview
10.9.3 Teva Pharmaceutical Gastrointestinal OTC Drugs Product Market Performance
10.9.4 Teva Pharmaceutical Business Overview
10.9.5 Teva Pharmaceutical Recent Developments
10.10 Nestle
10.10.1 Nestle Basic Information
10.10.2 Nestle Gastrointestinal OTC Drugs Product Overview
10.10.3 Nestle Gastrointestinal OTC Drugs Product Market Performance
10.10.4 Nestle Business Overview
10.10.5 Nestle Recent Developments
10.11 Boehringer Ingelheim
10.11.1 Boehringer Ingelheim Basic Information
10.11.2 Boehringer Ingelheim Gastrointestinal OTC Drugs Product Overview
10.11.3 Boehringer Ingelheim Gastrointestinal OTC Drugs Product Market Performance
10.11.4 Boehringer Ingelheim Business Overview
10.11.5 Boehringer Ingelheim Recent Developments
10.12 Reckitt Benckiser
10.12.1 Reckitt Benckiser Basic Information
10.12.2 Reckitt Benckiser Gastrointestinal OTC Drugs Product Overview
10.12.3 Reckitt Benckiser Gastrointestinal OTC Drugs Product Market Performance
10.12.4 Reckitt Benckiser Business Overview
10.12.5 Reckitt Benckiser Recent Developments
10.13 Purdue Pharma
10.13.1 Purdue Pharma Basic Information
10.13.2 Purdue Pharma Gastrointestinal OTC Drugs Product Overview
10.13.3 Purdue Pharma Gastrointestinal OTC Drugs Product Market Performance
10.13.4 Purdue Pharma Business Overview
10.13.5 Purdue Pharma Recent Developments
11 GASTROINTESTINAL OTC DRUGS MARKET FORECAST BY REGION
11.1 Global Gastrointestinal OTC Drugs Market Size Forecast
11.2 Global Gastrointestinal OTC Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Gastrointestinal OTC Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Gastrointestinal OTC Drugs Market Size Forecast by Region
11.2.4 South America Gastrointestinal OTC Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Gastrointestinal OTC Drugs by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Gastrointestinal OTC Drugs Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Gastrointestinal OTC Drugs by Type (2026-2035)
12.1.2 Global Gastrointestinal OTC Drugs Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Gastrointestinal OTC Drugs by Type (2026-2035)
12.2 Global Gastrointestinal OTC Drugs Market Forecast by Application (2026-2035)
12.2.1 Global Gastrointestinal OTC Drugs Sales (K MT) Forecast by Application
12.2.2 Global Gastrointestinal OTC Drugs Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Gastrointestinal OTC Drugs
1.2 Key Market Segments
1.2.1 Gastrointestinal OTC Drugs Segment by Type
1.2.2 Gastrointestinal OTC Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GASTROINTESTINAL OTC DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gastrointestinal OTC Drugs Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Gastrointestinal OTC Drugs Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GASTROINTESTINAL OTC DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Gastrointestinal OTC Drugs Product Life Cycle
3.3 Global Gastrointestinal OTC Drugs Sales by Manufacturers (2020-2025)
3.4 Global Gastrointestinal OTC Drugs Revenue Market Share by Manufacturers (2020-2025)
3.5 Gastrointestinal OTC Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Gastrointestinal OTC Drugs Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Gastrointestinal OTC Drugs Market Competitive Situation and Trends
3.8.1 Gastrointestinal OTC Drugs Market Concentration Rate
3.8.2 Global 5 and 10 Largest Gastrointestinal OTC Drugs Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GASTROINTESTINAL OTC DRUGS INDUSTRY CHAIN ANALYSIS
4.1 Gastrointestinal OTC Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GASTROINTESTINAL OTC DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Gastrointestinal OTC Drugs Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Gastrointestinal OTC Drugs Market
5.7 ESG Ratings of Leading Companies
6 GASTROINTESTINAL OTC DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gastrointestinal OTC Drugs Sales Market Share by Type (2020-2025)
6.3 Global Gastrointestinal OTC Drugs Market Size by Type (2020-2025)
6.4 Global Gastrointestinal OTC Drugs Price by Type (2020-2025)
7 GASTROINTESTINAL OTC DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gastrointestinal OTC Drugs Market Sales by Application (2020-2025)
7.3 Global Gastrointestinal OTC Drugs Market Size (M USD) by Application (2020-2025)
7.4 Global Gastrointestinal OTC Drugs Sales Growth Rate by Application (2020-2025)
8 GASTROINTESTINAL OTC DRUGS MARKET SALES BY REGION
8.1 Global Gastrointestinal OTC Drugs Sales by Region
8.1.1 Global Gastrointestinal OTC Drugs Sales by Region
8.1.2 Global Gastrointestinal OTC Drugs Sales Market Share by Region
8.2 Global Gastrointestinal OTC Drugs Market Size by Region
8.2.1 Global Gastrointestinal OTC Drugs Market Size by Region
8.2.2 Global Gastrointestinal OTC Drugs Market Size by Region
8.3 North America
8.3.1 North America Gastrointestinal OTC Drugs Sales by Country
8.3.2 North America Gastrointestinal OTC Drugs Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Gastrointestinal OTC Drugs Sales by Country
8.4.2 Europe Gastrointestinal OTC Drugs Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Gastrointestinal OTC Drugs Sales by Region
8.5.2 Asia Pacific Gastrointestinal OTC Drugs Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Gastrointestinal OTC Drugs Sales by Country
8.6.2 South America Gastrointestinal OTC Drugs Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Gastrointestinal OTC Drugs Sales by Region
8.7.2 Middle East and Africa Gastrointestinal OTC Drugs Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GASTROINTESTINAL OTC DRUGS MARKET PRODUCTION BY REGION
9.1 Global Production of Gastrointestinal OTC Drugs by Region(2020-2025)
9.2 Global Gastrointestinal OTC Drugs Revenue Market Share by Region (2020-2025)
9.3 Global Gastrointestinal OTC Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Gastrointestinal OTC Drugs Production
9.4.1 North America Gastrointestinal OTC Drugs Production Growth Rate (2020-2025)
9.4.2 North America Gastrointestinal OTC Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Gastrointestinal OTC Drugs Production
9.5.1 Europe Gastrointestinal OTC Drugs Production Growth Rate (2020-2025)
9.5.2 Europe Gastrointestinal OTC Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Gastrointestinal OTC Drugs Production (2020-2025)
9.6.1 Japan Gastrointestinal OTC Drugs Production Growth Rate (2020-2025)
9.6.2 Japan Gastrointestinal OTC Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Gastrointestinal OTC Drugs Production (2020-2025)
9.7.1 China Gastrointestinal OTC Drugs Production Growth Rate (2020-2025)
9.7.2 China Gastrointestinal OTC Drugs Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Basic Information
10.1.2 GlaxoSmithKline Gastrointestinal OTC Drugs Product Overview
10.1.3 GlaxoSmithKline Gastrointestinal OTC Drugs Product Market Performance
10.1.4 GlaxoSmithKline Business Overview
10.1.5 GlaxoSmithKline SWOT Analysis
10.1.6 GlaxoSmithKline Recent Developments
10.2 Pfizer
10.2.1 Pfizer Basic Information
10.2.2 Pfizer Gastrointestinal OTC Drugs Product Overview
10.2.3 Pfizer Gastrointestinal OTC Drugs Product Market Performance
10.2.4 Pfizer Business Overview
10.2.5 Pfizer SWOT Analysis
10.2.6 Pfizer Recent Developments
10.3 Johnson and Johnson
10.3.1 Johnson and Johnson Basic Information
10.3.2 Johnson and Johnson Gastrointestinal OTC Drugs Product Overview
10.3.3 Johnson and Johnson Gastrointestinal OTC Drugs Product Market Performance
10.3.4 Johnson and Johnson Business Overview
10.3.5 Johnson and Johnson SWOT Analysis
10.3.6 Johnson and Johnson Recent Developments
10.4 Bayer
10.4.1 Bayer Basic Information
10.4.2 Bayer Gastrointestinal OTC Drugs Product Overview
10.4.3 Bayer Gastrointestinal OTC Drugs Product Market Performance
10.4.4 Bayer Business Overview
10.4.5 Bayer Recent Developments
10.5 Procter and Gamble
10.5.1 Procter and Gamble Basic Information
10.5.2 Procter and Gamble Gastrointestinal OTC Drugs Product Overview
10.5.3 Procter and Gamble Gastrointestinal OTC Drugs Product Market Performance
10.5.4 Procter and Gamble Business Overview
10.5.5 Procter and Gamble Recent Developments
10.6 Perrigo
10.6.1 Perrigo Basic Information
10.6.2 Perrigo Gastrointestinal OTC Drugs Product Overview
10.6.3 Perrigo Gastrointestinal OTC Drugs Product Market Performance
10.6.4 Perrigo Business Overview
10.6.5 Perrigo Recent Developments
10.7 Abbott
10.7.1 Abbott Basic Information
10.7.2 Abbott Gastrointestinal OTC Drugs Product Overview
10.7.3 Abbott Gastrointestinal OTC Drugs Product Market Performance
10.7.4 Abbott Business Overview
10.7.5 Abbott Recent Developments
10.8 Sanofi
10.8.1 Sanofi Basic Information
10.8.2 Sanofi Gastrointestinal OTC Drugs Product Overview
10.8.3 Sanofi Gastrointestinal OTC Drugs Product Market Performance
10.8.4 Sanofi Business Overview
10.8.5 Sanofi Recent Developments
10.9 Teva Pharmaceutical
10.9.1 Teva Pharmaceutical Basic Information
10.9.2 Teva Pharmaceutical Gastrointestinal OTC Drugs Product Overview
10.9.3 Teva Pharmaceutical Gastrointestinal OTC Drugs Product Market Performance
10.9.4 Teva Pharmaceutical Business Overview
10.9.5 Teva Pharmaceutical Recent Developments
10.10 Nestle
10.10.1 Nestle Basic Information
10.10.2 Nestle Gastrointestinal OTC Drugs Product Overview
10.10.3 Nestle Gastrointestinal OTC Drugs Product Market Performance
10.10.4 Nestle Business Overview
10.10.5 Nestle Recent Developments
10.11 Boehringer Ingelheim
10.11.1 Boehringer Ingelheim Basic Information
10.11.2 Boehringer Ingelheim Gastrointestinal OTC Drugs Product Overview
10.11.3 Boehringer Ingelheim Gastrointestinal OTC Drugs Product Market Performance
10.11.4 Boehringer Ingelheim Business Overview
10.11.5 Boehringer Ingelheim Recent Developments
10.12 Reckitt Benckiser
10.12.1 Reckitt Benckiser Basic Information
10.12.2 Reckitt Benckiser Gastrointestinal OTC Drugs Product Overview
10.12.3 Reckitt Benckiser Gastrointestinal OTC Drugs Product Market Performance
10.12.4 Reckitt Benckiser Business Overview
10.12.5 Reckitt Benckiser Recent Developments
10.13 Purdue Pharma
10.13.1 Purdue Pharma Basic Information
10.13.2 Purdue Pharma Gastrointestinal OTC Drugs Product Overview
10.13.3 Purdue Pharma Gastrointestinal OTC Drugs Product Market Performance
10.13.4 Purdue Pharma Business Overview
10.13.5 Purdue Pharma Recent Developments
11 GASTROINTESTINAL OTC DRUGS MARKET FORECAST BY REGION
11.1 Global Gastrointestinal OTC Drugs Market Size Forecast
11.2 Global Gastrointestinal OTC Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Gastrointestinal OTC Drugs Market Size Forecast by Country
11.2.3 Asia Pacific Gastrointestinal OTC Drugs Market Size Forecast by Region
11.2.4 South America Gastrointestinal OTC Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Gastrointestinal OTC Drugs by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Gastrointestinal OTC Drugs Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Gastrointestinal OTC Drugs by Type (2026-2035)
12.1.2 Global Gastrointestinal OTC Drugs Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Gastrointestinal OTC Drugs by Type (2026-2035)
12.2 Global Gastrointestinal OTC Drugs Market Forecast by Application (2026-2035)
12.2.1 Global Gastrointestinal OTC Drugs Sales (K MT) Forecast by Application
12.2.2 Global Gastrointestinal OTC Drugs Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Gastrointestinal OTC Drugs Market Size by Type (M USD)
Table 4. Global Gastrointestinal OTC Drugs Market Size by Application
Table 5. Gastrointestinal OTC Drugs Market Size Comparison by Region (M USD)
Table 6. Global Gastrointestinal OTC Drugs Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Gastrointestinal OTC Drugs Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Gastrointestinal OTC Drugs Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Gastrointestinal OTC Drugs Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal OTC Drugs as of 2025)
Table 11. Global Market Gastrointestinal OTC Drugs Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Gastrointestinal OTC Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gastrointestinal OTC Drugs Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Gastrointestinal OTC Drugs Sales by Type (K MT)
Table 27. Global Gastrointestinal OTC Drugs Market Size by Type (M USD)
Table 28. Global Gastrointestinal OTC Drugs Sales (K MT) by Type (2020-2025)
Table 29. Global Gastrointestinal OTC Drugs Sales Market Share by Type (2020-2025)
Table 30. Global Gastrointestinal OTC Drugs Market Size (M USD) by Type (2020-2025)
Table 31. Global Gastrointestinal OTC Drugs Market Share by Type (2020-2025)
Table 32. Global Gastrointestinal OTC Drugs Price (USD/KG) by Type (2020-2025)
Table 33. Global Gastrointestinal OTC Drugs Sales (K MT) by Application
Table 34. Global Gastrointestinal OTC Drugs Market Size by Application
Table 35. Global Gastrointestinal OTC Drugs Sales by Application (2020-2025) & (K MT)
Table 36. Global Gastrointestinal OTC Drugs Sales Market Share by Application (2020-2025)
Table 37. Global Gastrointestinal OTC Drugs Market Size by Application (2020-2025) & (M USD)
Table 38. Global Gastrointestinal OTC Drugs Market Share by Application (2020-2025)
Table 39. Global Gastrointestinal OTC Drugs Sales Growth Rate by Application (2020-2025)
Table 40. Global Gastrointestinal OTC Drugs Sales by Region (2020-2025) & (K MT)
Table 41. Global Gastrointestinal OTC Drugs Sales Market Share by Region (2020-2025)
Table 42. Global Gastrointestinal OTC Drugs Market Size by Region (2020-2025) & (M USD)
Table 43. Global Gastrointestinal OTC Drugs Market Size by Region (2020-2025)
Table 44. North America Gastrointestinal OTC Drugs Sales by Country (2020-2025) & (K MT)
Table 45. North America Gastrointestinal OTC Drugs Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Gastrointestinal OTC Drugs Sales by Country (2020-2025) & (K MT)
Table 47. Europe Gastrointestinal OTC Drugs Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Gastrointestinal OTC Drugs Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Gastrointestinal OTC Drugs Market Size by Region (2020-2025) & (M USD)
Table 50. South America Gastrointestinal OTC Drugs Sales by Country (2020-2025) & (K MT)
Table 51. South America Gastrointestinal OTC Drugs Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Gastrointestinal OTC Drugs Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Gastrointestinal OTC Drugs Market Size by Region (2020-2025) & (M USD)
Table 54. Global Gastrointestinal OTC Drugs Production (K MT) by Region(2020-2025)
Table 55. Global Gastrointestinal OTC Drugs Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Gastrointestinal OTC Drugs Revenue Market Share by Region (2020-2025)
Table 57. Global Gastrointestinal OTC Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Gastrointestinal OTC Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Gastrointestinal OTC Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Gastrointestinal OTC Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Gastrointestinal OTC Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. GlaxoSmithKline Basic Information
Table 63. GlaxoSmithKline Gastrointestinal OTC Drugs Product Overview
Table 64. GlaxoSmithKline Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. GlaxoSmithKline Business Overview
Table 66. GlaxoSmithKline SWOT Analysis
Table 67. GlaxoSmithKline Recent Developments
Table 68. Pfizer Basic Information
Table 69. Pfizer Gastrointestinal OTC Drugs Product Overview
Table 70. Pfizer Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Pfizer Business Overview
Table 72. Pfizer SWOT Analysis
Table 73. Pfizer Recent Developments
Table 74. Johnson and Johnson Basic Information
Table 75. Johnson and Johnson Gastrointestinal OTC Drugs Product Overview
Table 76. Johnson and Johnson Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Johnson and Johnson Business Overview
Table 78. Johnson and Johnson SWOT Analysis
Table 79. Johnson and Johnson Recent Developments
Table 80. Bayer Basic Information
Table 81. Bayer Gastrointestinal OTC Drugs Product Overview
Table 82. Bayer Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Bayer Business Overview
Table 84. Bayer Recent Developments
Table 85. Procter and Gamble Basic Information
Table 86. Procter and Gamble Gastrointestinal OTC Drugs Product Overview
Table 87. Procter and Gamble Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Procter and Gamble Business Overview
Table 89. Procter and Gamble Recent Developments
Table 90. Perrigo Basic Information
Table 91. Perrigo Gastrointestinal OTC Drugs Product Overview
Table 92. Perrigo Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Perrigo Business Overview
Table 94. Perrigo Recent Developments
Table 95. Abbott Basic Information
Table 96. Abbott Gastrointestinal OTC Drugs Product Overview
Table 97. Abbott Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Abbott Business Overview
Table 99. Abbott Recent Developments
Table 100. Sanofi Basic Information
Table 101. Sanofi Gastrointestinal OTC Drugs Product Overview
Table 102. Sanofi Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Sanofi Business Overview
Table 104. Sanofi Recent Developments
Table 105. Teva Pharmaceutical Basic Information
Table 106. Teva Pharmaceutical Gastrointestinal OTC Drugs Product Overview
Table 107. Teva Pharmaceutical Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Teva Pharmaceutical Business Overview
Table 109. Teva Pharmaceutical Recent Developments
Table 110. Nestle Basic Information
Table 111. Nestle Gastrointestinal OTC Drugs Product Overview
Table 112. Nestle Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Nestle Business Overview
Table 114. Nestle Recent Developments
Table 115. Boehringer Ingelheim Basic Information
Table 116. Boehringer Ingelheim Gastrointestinal OTC Drugs Product Overview
Table 117. Boehringer Ingelheim Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Boehringer Ingelheim Business Overview
Table 119. Boehringer Ingelheim Recent Developments
Table 120. Reckitt Benckiser Basic Information
Table 121. Reckitt Benckiser Gastrointestinal OTC Drugs Product Overview
Table 122. Reckitt Benckiser Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Reckitt Benckiser Business Overview
Table 124. Reckitt Benckiser Recent Developments
Table 125. Purdue Pharma Basic Information
Table 126. Purdue Pharma Gastrointestinal OTC Drugs Product Overview
Table 127. Purdue Pharma Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Purdue Pharma Business Overview
Table 129. Purdue Pharma Recent Developments
Table 130. Global Gastrointestinal OTC Drugs Sales Forecast by Region (2026-2035) & (K MT)
Table 131. Global Gastrointestinal OTC Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 132. North America Gastrointestinal OTC Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 133. North America Gastrointestinal OTC Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 134. Europe Gastrointestinal OTC Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 135. Europe Gastrointestinal OTC Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 136. Asia Pacific Gastrointestinal OTC Drugs Sales Forecast by Region (2026-2035) & (K MT)
Table 137. Asia Pacific Gastrointestinal OTC Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 138. South America Gastrointestinal OTC Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 139. South America Gastrointestinal OTC Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 140. Middle East and Africa Gastrointestinal OTC Drugs Sales Forecast by Country (2026-2035) & (Units)
Table 141. Middle East and Africa Gastrointestinal OTC Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 142. Global Gastrointestinal OTC Drugs Sales Forecast by Type (2026-2035) & (K MT)
Table 143. Global Gastrointestinal OTC Drugs Market Size Forecast by Type (2026-2035) & (M USD)
Table 144. Global Gastrointestinal OTC Drugs Price Forecast by Type (2026-2035) & (USD/KG)
Table 145. Global Gastrointestinal OTC Drugs Sales (K MT) Forecast by Application (2026-2035)
Table 146. Global Gastrointestinal OTC Drugs Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Gastrointestinal OTC Drugs Market Size by Type (M USD)
Table 4. Global Gastrointestinal OTC Drugs Market Size by Application
Table 5. Gastrointestinal OTC Drugs Market Size Comparison by Region (M USD)
Table 6. Global Gastrointestinal OTC Drugs Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Gastrointestinal OTC Drugs Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Gastrointestinal OTC Drugs Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Gastrointestinal OTC Drugs Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal OTC Drugs as of 2025)
Table 11. Global Market Gastrointestinal OTC Drugs Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Gastrointestinal OTC Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Gastrointestinal OTC Drugs Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Gastrointestinal OTC Drugs Sales by Type (K MT)
Table 27. Global Gastrointestinal OTC Drugs Market Size by Type (M USD)
Table 28. Global Gastrointestinal OTC Drugs Sales (K MT) by Type (2020-2025)
Table 29. Global Gastrointestinal OTC Drugs Sales Market Share by Type (2020-2025)
Table 30. Global Gastrointestinal OTC Drugs Market Size (M USD) by Type (2020-2025)
Table 31. Global Gastrointestinal OTC Drugs Market Share by Type (2020-2025)
Table 32. Global Gastrointestinal OTC Drugs Price (USD/KG) by Type (2020-2025)
Table 33. Global Gastrointestinal OTC Drugs Sales (K MT) by Application
Table 34. Global Gastrointestinal OTC Drugs Market Size by Application
Table 35. Global Gastrointestinal OTC Drugs Sales by Application (2020-2025) & (K MT)
Table 36. Global Gastrointestinal OTC Drugs Sales Market Share by Application (2020-2025)
Table 37. Global Gastrointestinal OTC Drugs Market Size by Application (2020-2025) & (M USD)
Table 38. Global Gastrointestinal OTC Drugs Market Share by Application (2020-2025)
Table 39. Global Gastrointestinal OTC Drugs Sales Growth Rate by Application (2020-2025)
Table 40. Global Gastrointestinal OTC Drugs Sales by Region (2020-2025) & (K MT)
Table 41. Global Gastrointestinal OTC Drugs Sales Market Share by Region (2020-2025)
Table 42. Global Gastrointestinal OTC Drugs Market Size by Region (2020-2025) & (M USD)
Table 43. Global Gastrointestinal OTC Drugs Market Size by Region (2020-2025)
Table 44. North America Gastrointestinal OTC Drugs Sales by Country (2020-2025) & (K MT)
Table 45. North America Gastrointestinal OTC Drugs Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Gastrointestinal OTC Drugs Sales by Country (2020-2025) & (K MT)
Table 47. Europe Gastrointestinal OTC Drugs Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Gastrointestinal OTC Drugs Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Gastrointestinal OTC Drugs Market Size by Region (2020-2025) & (M USD)
Table 50. South America Gastrointestinal OTC Drugs Sales by Country (2020-2025) & (K MT)
Table 51. South America Gastrointestinal OTC Drugs Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Gastrointestinal OTC Drugs Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Gastrointestinal OTC Drugs Market Size by Region (2020-2025) & (M USD)
Table 54. Global Gastrointestinal OTC Drugs Production (K MT) by Region(2020-2025)
Table 55. Global Gastrointestinal OTC Drugs Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Gastrointestinal OTC Drugs Revenue Market Share by Region (2020-2025)
Table 57. Global Gastrointestinal OTC Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Gastrointestinal OTC Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Gastrointestinal OTC Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Gastrointestinal OTC Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Gastrointestinal OTC Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. GlaxoSmithKline Basic Information
Table 63. GlaxoSmithKline Gastrointestinal OTC Drugs Product Overview
Table 64. GlaxoSmithKline Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. GlaxoSmithKline Business Overview
Table 66. GlaxoSmithKline SWOT Analysis
Table 67. GlaxoSmithKline Recent Developments
Table 68. Pfizer Basic Information
Table 69. Pfizer Gastrointestinal OTC Drugs Product Overview
Table 70. Pfizer Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Pfizer Business Overview
Table 72. Pfizer SWOT Analysis
Table 73. Pfizer Recent Developments
Table 74. Johnson and Johnson Basic Information
Table 75. Johnson and Johnson Gastrointestinal OTC Drugs Product Overview
Table 76. Johnson and Johnson Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Johnson and Johnson Business Overview
Table 78. Johnson and Johnson SWOT Analysis
Table 79. Johnson and Johnson Recent Developments
Table 80. Bayer Basic Information
Table 81. Bayer Gastrointestinal OTC Drugs Product Overview
Table 82. Bayer Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Bayer Business Overview
Table 84. Bayer Recent Developments
Table 85. Procter and Gamble Basic Information
Table 86. Procter and Gamble Gastrointestinal OTC Drugs Product Overview
Table 87. Procter and Gamble Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Procter and Gamble Business Overview
Table 89. Procter and Gamble Recent Developments
Table 90. Perrigo Basic Information
Table 91. Perrigo Gastrointestinal OTC Drugs Product Overview
Table 92. Perrigo Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Perrigo Business Overview
Table 94. Perrigo Recent Developments
Table 95. Abbott Basic Information
Table 96. Abbott Gastrointestinal OTC Drugs Product Overview
Table 97. Abbott Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Abbott Business Overview
Table 99. Abbott Recent Developments
Table 100. Sanofi Basic Information
Table 101. Sanofi Gastrointestinal OTC Drugs Product Overview
Table 102. Sanofi Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Sanofi Business Overview
Table 104. Sanofi Recent Developments
Table 105. Teva Pharmaceutical Basic Information
Table 106. Teva Pharmaceutical Gastrointestinal OTC Drugs Product Overview
Table 107. Teva Pharmaceutical Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Teva Pharmaceutical Business Overview
Table 109. Teva Pharmaceutical Recent Developments
Table 110. Nestle Basic Information
Table 111. Nestle Gastrointestinal OTC Drugs Product Overview
Table 112. Nestle Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Nestle Business Overview
Table 114. Nestle Recent Developments
Table 115. Boehringer Ingelheim Basic Information
Table 116. Boehringer Ingelheim Gastrointestinal OTC Drugs Product Overview
Table 117. Boehringer Ingelheim Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Boehringer Ingelheim Business Overview
Table 119. Boehringer Ingelheim Recent Developments
Table 120. Reckitt Benckiser Basic Information
Table 121. Reckitt Benckiser Gastrointestinal OTC Drugs Product Overview
Table 122. Reckitt Benckiser Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Reckitt Benckiser Business Overview
Table 124. Reckitt Benckiser Recent Developments
Table 125. Purdue Pharma Basic Information
Table 126. Purdue Pharma Gastrointestinal OTC Drugs Product Overview
Table 127. Purdue Pharma Gastrointestinal OTC Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Purdue Pharma Business Overview
Table 129. Purdue Pharma Recent Developments
Table 130. Global Gastrointestinal OTC Drugs Sales Forecast by Region (2026-2035) & (K MT)
Table 131. Global Gastrointestinal OTC Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 132. North America Gastrointestinal OTC Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 133. North America Gastrointestinal OTC Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 134. Europe Gastrointestinal OTC Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 135. Europe Gastrointestinal OTC Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 136. Asia Pacific Gastrointestinal OTC Drugs Sales Forecast by Region (2026-2035) & (K MT)
Table 137. Asia Pacific Gastrointestinal OTC Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 138. South America Gastrointestinal OTC Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 139. South America Gastrointestinal OTC Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 140. Middle East and Africa Gastrointestinal OTC Drugs Sales Forecast by Country (2026-2035) & (Units)
Table 141. Middle East and Africa Gastrointestinal OTC Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 142. Global Gastrointestinal OTC Drugs Sales Forecast by Type (2026-2035) & (K MT)
Table 143. Global Gastrointestinal OTC Drugs Market Size Forecast by Type (2026-2035) & (M USD)
Table 144. Global Gastrointestinal OTC Drugs Price Forecast by Type (2026-2035) & (USD/KG)
Table 145. Global Gastrointestinal OTC Drugs Sales (K MT) Forecast by Application (2026-2035)
Table 146. Global Gastrointestinal OTC Drugs Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Gastrointestinal OTC Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gastrointestinal OTC Drugs Market Size (M USD), 2025-2035
Figure 5. Global Gastrointestinal OTC Drugs Market Size (M USD) (2020-2035)
Figure 6. Global Gastrointestinal OTC Drugs Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gastrointestinal OTC Drugs Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Gastrointestinal OTC Drugs Product Life Cycle
Figure 13. Gastrointestinal OTC Drugs Sales Share by Manufacturers in 2025
Figure 14. Global Gastrointestinal OTC Drugs Revenue Share by Manufacturers in 2025
Figure 15. Gastrointestinal OTC Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Gastrointestinal OTC Drugs Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Gastrointestinal OTC Drugs Revenue in 2025
Figure 18. Industry Chain Map of Gastrointestinal OTC Drugs
Figure 19. Global Gastrointestinal OTC Drugs Market PEST Analysis
Figure 20. Global Gastrointestinal OTC Drugs Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Gastrointestinal OTC Drugs Market Share by Type
Figure 27. Sales Market Share of Gastrointestinal OTC Drugs by Type (2020-2025)
Figure 28. Sales Market Share of Gastrointestinal OTC Drugs by Type in 2025
Figure 29. Market Share of Gastrointestinal OTC Drugs by Type (2020-2025)
Figure 30. Market Share of Gastrointestinal OTC Drugs by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Gastrointestinal OTC Drugs Market Share by Application
Figure 33. Global Gastrointestinal OTC Drugs Sales Market Share by Application (2020-2025)
Figure 34. Global Gastrointestinal OTC Drugs Sales Market Share by Application in 2025
Figure 35. Global Gastrointestinal OTC Drugs Market Share by Application (2020-2025)
Figure 36. Global Gastrointestinal OTC Drugs Market Share by Application in 2025
Figure 37. Global Gastrointestinal OTC Drugs Sales Growth Rate by Application (2020-2025)
Figure 38. Global Gastrointestinal OTC Drugs Sales Market Share by Region (2020-2025)
Figure 39. Global Gastrointestinal OTC Drugs Market Size by Region (2020-2025)
Figure 40. North America Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Gastrointestinal OTC Drugs Sales Market Share by Country in 2024
Figure 43. North America Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Gastrointestinal OTC Drugs Market Size by Country in 2024
Figure 45. U.S. Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Gastrointestinal OTC Drugs Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Gastrointestinal OTC Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Gastrointestinal OTC Drugs Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Gastrointestinal OTC Drugs Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Gastrointestinal OTC Drugs Sales Market Share by Country in 2024
Figure 53. Europe Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Gastrointestinal OTC Drugs Market Size by Country in 2024
Figure 55. Germany Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Gastrointestinal OTC Drugs Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Gastrointestinal OTC Drugs Sales Market Share by Region in 2024
Figure 67. Asia Pacific Gastrointestinal OTC Drugs Market Size by Region in 2024
Figure 68. China Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Gastrointestinal OTC Drugs Sales and Growth Rate (K MT)
Figure 79. South America Gastrointestinal OTC Drugs Sales Market Share by Country in 2024
Figure 80. South America Gastrointestinal OTC Drugs Market Size and Growth Rate (M USD)
Figure 81. South America Gastrointestinal OTC Drugs Market Size by Country in 2024
Figure 82. Brazil Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Gastrointestinal OTC Drugs Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Gastrointestinal OTC Drugs Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Gastrointestinal OTC Drugs Market Size by Region in 2024
Figure 92. Saudi Arabia Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Gastrointestinal OTC Drugs Production Market Share by Region (2020-2025)
Figure 103. North America Gastrointestinal OTC Drugs Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Gastrointestinal OTC Drugs Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Gastrointestinal OTC Drugs Production (K MT) Growth Rate (2020-2025)
Figure 106. China Gastrointestinal OTC Drugs Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Gastrointestinal OTC Drugs Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Gastrointestinal OTC Drugs Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Gastrointestinal OTC Drugs Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Gastrointestinal OTC Drugs Market Share Forecast by Type (2026-2035)
Figure 111. Global Gastrointestinal OTC Drugs Sales Forecast by Application (2026-2035)
Figure 112. Global Gastrointestinal OTC Drugs Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Gastrointestinal OTC Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gastrointestinal OTC Drugs Market Size (M USD), 2025-2035
Figure 5. Global Gastrointestinal OTC Drugs Market Size (M USD) (2020-2035)
Figure 6. Global Gastrointestinal OTC Drugs Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gastrointestinal OTC Drugs Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Gastrointestinal OTC Drugs Product Life Cycle
Figure 13. Gastrointestinal OTC Drugs Sales Share by Manufacturers in 2025
Figure 14. Global Gastrointestinal OTC Drugs Revenue Share by Manufacturers in 2025
Figure 15. Gastrointestinal OTC Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Gastrointestinal OTC Drugs Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Gastrointestinal OTC Drugs Revenue in 2025
Figure 18. Industry Chain Map of Gastrointestinal OTC Drugs
Figure 19. Global Gastrointestinal OTC Drugs Market PEST Analysis
Figure 20. Global Gastrointestinal OTC Drugs Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Gastrointestinal OTC Drugs Market Share by Type
Figure 27. Sales Market Share of Gastrointestinal OTC Drugs by Type (2020-2025)
Figure 28. Sales Market Share of Gastrointestinal OTC Drugs by Type in 2025
Figure 29. Market Share of Gastrointestinal OTC Drugs by Type (2020-2025)
Figure 30. Market Share of Gastrointestinal OTC Drugs by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Gastrointestinal OTC Drugs Market Share by Application
Figure 33. Global Gastrointestinal OTC Drugs Sales Market Share by Application (2020-2025)
Figure 34. Global Gastrointestinal OTC Drugs Sales Market Share by Application in 2025
Figure 35. Global Gastrointestinal OTC Drugs Market Share by Application (2020-2025)
Figure 36. Global Gastrointestinal OTC Drugs Market Share by Application in 2025
Figure 37. Global Gastrointestinal OTC Drugs Sales Growth Rate by Application (2020-2025)
Figure 38. Global Gastrointestinal OTC Drugs Sales Market Share by Region (2020-2025)
Figure 39. Global Gastrointestinal OTC Drugs Market Size by Region (2020-2025)
Figure 40. North America Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Gastrointestinal OTC Drugs Sales Market Share by Country in 2024
Figure 43. North America Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Gastrointestinal OTC Drugs Market Size by Country in 2024
Figure 45. U.S. Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Gastrointestinal OTC Drugs Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Gastrointestinal OTC Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Gastrointestinal OTC Drugs Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Gastrointestinal OTC Drugs Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Gastrointestinal OTC Drugs Sales Market Share by Country in 2024
Figure 53. Europe Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Gastrointestinal OTC Drugs Market Size by Country in 2024
Figure 55. Germany Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Gastrointestinal OTC Drugs Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Gastrointestinal OTC Drugs Sales Market Share by Region in 2024
Figure 67. Asia Pacific Gastrointestinal OTC Drugs Market Size by Region in 2024
Figure 68. China Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Gastrointestinal OTC Drugs Sales and Growth Rate (K MT)
Figure 79. South America Gastrointestinal OTC Drugs Sales Market Share by Country in 2024
Figure 80. South America Gastrointestinal OTC Drugs Market Size and Growth Rate (M USD)
Figure 81. South America Gastrointestinal OTC Drugs Market Size by Country in 2024
Figure 82. Brazil Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Gastrointestinal OTC Drugs Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Gastrointestinal OTC Drugs Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Gastrointestinal OTC Drugs Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Gastrointestinal OTC Drugs Market Size by Region in 2024
Figure 92. Saudi Arabia Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Gastrointestinal OTC Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Gastrointestinal OTC Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Gastrointestinal OTC Drugs Production Market Share by Region (2020-2025)
Figure 103. North America Gastrointestinal OTC Drugs Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Gastrointestinal OTC Drugs Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Gastrointestinal OTC Drugs Production (K MT) Growth Rate (2020-2025)
Figure 106. China Gastrointestinal OTC Drugs Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Gastrointestinal OTC Drugs Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Gastrointestinal OTC Drugs Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Gastrointestinal OTC Drugs Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Gastrointestinal OTC Drugs Market Share Forecast by Type (2026-2035)
Figure 111. Global Gastrointestinal OTC Drugs Sales Forecast by Application (2026-2035)
Figure 112. Global Gastrointestinal OTC Drugs Market Share Forecast by Application (2026-2035)
